<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tbjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Туберкулез и социально значимые заболевания</journal-title><trans-title-group xml:lang="en"><trans-title>Tuberculosis and socially significant diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2413-0346</issn><issn pub-type="epub">2413-0354</issn><publisher><publisher-name>ООО «Ин-Тренд</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">tbjournal-335</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>К механизмам регуляции туберкулезного воспаления</article-title><trans-title-group xml:lang="en"><trans-title>TO THE MECHAMISNS OF REGULATION OF TIBERCULOSIS INFLAMMATION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гергерт</surname><given-names>В. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Herhert</surname><given-names>V. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гергерт Владислав Яковлевич – заведующий отделом иммунологии ФГБНУ «Центральный научно-исследовательский институт туберкулеза», Москва, доктор медицинских наук, профессор</p><p>107564, г. Москва, Яузская аллея, д. 2Тел.: + 7 (499) 785-90-72</p></bio><email xlink:type="simple">hergertv@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремеев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Eremeev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Еремеев Владимир Витальевич – заведующий лабораторией клинической иммуногенетики и клеточных технологий ФГБНУ «Центральный научно-исследовательский институт туберкулеза», Москва, доктор медицинских наук</p><p>107564, г. Москва, Яузская аллея, д. 2Тел.: + 7 (499) 785-90-72</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБНУ «Центральный научно-исследовательский институт туберкулеза»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>28</day><month>01</month><year>2025</year></pub-date><volume>0</volume><issue>2</issue><fpage>54</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гергерт В.Я., Еремеев В.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Гергерт В.Я., Еремеев В.В.</copyright-holder><copyright-holder xml:lang="en">Herhert V.Y., Eremeev V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tb-journal.ru/jour/article/view/335">https://www.tb-journal.ru/jour/article/view/335</self-uri><abstract><p>В настоящем исследовании рассматривается влияние одного из механизмов регуляции туберкулезного воспаления, а именно сигнала, передаваемого через рецептор (IFNAR1) для интерферонов I типа на течение экспериментального туберкулеза у мышей. На основании изучения особенностей течения заболевания у мышей дикого типа линии 129S2 и Ifnar1-/- мышей на той же генетической основе показано, что сигнал, передаваемый через IFNAR1-рецептор, ухудшает течение экспериментального туберкулеза; не препятствует размножению микобактерий туберкулеза в легких; не оказывает существенного влияния на формирование иммунного ответа на вакцинацию BCG; усиливает приток нейтрофилов в легкие с перераспределением микобактерий в эти клеточные элементы; способствует ускоренному развитию патологии и гибель зараженных мышей.</p></abstract><trans-abstract xml:lang="en"><p>The present study reviewed the role of one of the mechanisms of regulation of tuberculous inflammation, namely, a signal transmitted through the receptor (IFNAR1) for type I interferons in the course of experimental tuberculosis in mice. On the basis of studying of the characteristics of the course of TB in wild-type mice of 129S2 line and Ifnar1-/- mice on the same genetic basis we have shown that the signal transmitted through the IFNAR1-receptor worsens the course of experimental tuberculosis; It don’t prevent the proliferation of Mycobacterium tuberculosis in the lungs; It has no impact on the formation of an immune response to the BCG vaccine; It enhances the influx of neutrophils into the lungs with the redistribution of mycobacteria in these cellular elements; It serves to the accelerated development of the pathology and death of infected mice.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>интерферон I типа</kwd><kwd>экспериментальный туберкулез у мышей</kwd><kwd>хроническое воспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 1 interferon</kwd><kwd>experimental tuberculosis in mice</kwd><kwd>chronic inflammation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Behar S., Martin C., Booty M. et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. // Mucosal. Immunol. – 2011. – Vol. 4. – P. 279-287.</mixed-citation><mixed-citation xml:lang="en">Behar S., Martin C., Booty M. et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. // Mucosal. Immunol. – 2011. – Vol. 4. – P. 279-287.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bellamy R., Hill A. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. // Current Opinion in Immunology. – 1998. – Vol. 10. – P. 483-487.</mixed-citation><mixed-citation xml:lang="en">Bellamy R., Hill A. Genetic susceptibility to mycobacteria and other infectious pathogens in humans. // Current Opinion in Immunology. – 1998. – Vol. 10. – P. 483-487.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Briken V., Miller J. Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis. // Future Microbiol. – 2008. – Vol. 3. – P. 415-422.</mixed-citation><mixed-citation xml:lang="en">Briken V., Miller J. Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis. // Future Microbiol. – 2008. – Vol. 3. – P. 415-422.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Comas I., Chakravartti J., Small P. et al. Human T-cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. // Nat. Genet. – 2010. – Vol. 42. – P. 498-503.</mixed-citation><mixed-citation xml:lang="en">Comas I., Chakravartti J., Small P. et al. Human T-cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. // Nat. Genet. – 2010. – Vol. 42. – P. 498-503.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Eruslanov E., Lyadova I., Kondratieva T. et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. // Infect. Immun. – 2005. – Vol. 73. – P. 1744-1753.</mixed-citation><mixed-citation xml:lang="en">Eruslanov E., Lyadova I., Kondratieva T. et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. // Infect. Immun. – 2005. – Vol. 73. – P. 1744-1753.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fremond C., Yeremeev V., Nicolle D. et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. // J. Clinical. Investigations. - 2004.</mixed-citation><mixed-citation xml:lang="en">Fremond C., Yeremeev V., Nicolle D. et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. // J. Clinical. Investigations. - 2004.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fu L. The potential of human neutrophil peptides in tuberculosis therapy. // Int. J. Tuberc. Lung. Dis. – 2003. – Vol. 7. – P. 1027-1032.</mixed-citation><mixed-citation xml:lang="en">Fu L. The potential of human neutrophil peptides in tuberculosis therapy. // Int. J. Tuberc. Lung. Dis. – 2003. – Vol. 7. – P. 1027-1032.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Oberst A., Pop C., Tremblay A. et al. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. // J. Biol. Chem. – 2010. – Vol. 285. – P. 16632-16642.</mixed-citation><mixed-citation xml:lang="en">Oberst A., Pop C., Tremblay A. et al. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. // J. Biol. Chem. – 2010. – Vol. 285. – P. 16632-16642.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez F., Radaeva T., Nikonenko B. et al. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. // Infect. Immun. – 2003. – Vol. 71. – P. 126-131.</mixed-citation><mixed-citation xml:lang="en">Sanchez F., Radaeva T., Nikonenko B. et al. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. // Infect. Immun. – 2003. – Vol. 71. – P. 126-131.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
